PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Return
55.85%
This Quarter Return
+8.55%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$5.41B
AUM Growth
+$174M
(+3.3%)
Cap. Flow
-$97.1M
Cap. Flow
% of AUM
-1.8%
Top 10 Holdings %
Top 10 Hldgs %
21.52%
Holding
287
New
40
Increased
91
Reduced
93
Closed
30
Top Buys
| 1 |
Merck
MRK
|
$53.9M |
| 2 |
Canadian Natural Resources
CNQ
|
$52.7M |
| 3 |
Abbott
ABT
|
$36.8M |
| 4 |
Amgen
AMGN
|
$34.6M |
| 5 |
Edwards Lifesciences
EW
|
$29.3M |
Top Sells
| 1 |
Pfizer
PFE
|
$63.6M |
| 2 |
N
Netsuite Inc
N
|
$43.9M |
| 3 |
AGN
Allergan plc
AGN
|
$39.6M |
| 4 |
eBay
EBAY
|
$34.2M |
| 5 |
BCR
CR Bard Inc.
BCR
|
$33.1M |
Sector Composition
| 1 | Technology | 23.12% |
| 2 | Healthcare | 22.69% |
| 3 | Financials | 21.9% |
| 4 | Communication Services | 10.68% |
| 5 | Consumer Discretionary | 5.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVTA
226
DELISTED
Invitae Corporation
NVTA
| $416K | 0.01% |
47,500
-7,500
| -14% | -$65.7K |
|
227
Coherus Oncology, Inc. Common Stock
CHRS
$152M
| $402K | 0.01% |
+15,000
| New | +$402K |
|
228
Ocular Therapeutix
OCUL
$2.21B
| $395K | 0.01% |
57,500
-17,373
| -23% | -$119K |
|
229
Acadia Pharmaceuticals
ACAD
$4.3B
| $358K | 0.01% |
11,250
-19,143
| -63% | -$609K |
|
|
ISEE
230
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $334K | 0.01% |
7,250
-35,826
| -83% | -$1.65M |
|
231
KeyCorp
KEY
$21B
| $324K | 0.01% |
+26,663
| New | +$324K |
|
|
HSTO
232
DELISTED
Histogen Inc. Common Stock
HSTO
| $311K | 0.01% |
783
| – | – |
|
233
iShares MSCI Emerging Markets ETF
EEM
$19B
| $253K | ﹤0.01% |
+6,762
| New | +$253K |
|
234
TSMC
TSM
$1.22T
| $203K | ﹤0.01% |
+6,640
| New | +$203K |
|
235
Alcoa
AA
$8.1B
| – | – |
-36,457
| Closed | -$812K |
|
236
Acadia Healthcare
ACHC
$2.18B
| – | – |
-330,000
| Closed | -$18.3M |
|
237
Alamos Gold
AGI
$13.3B
| – | – |
-325,000
| Closed | -$2.72M |
|
238
Align Technology
ALGN
$9.76B
| – | – |
-120,000
| Closed | -$9.67M |
|
239
Alkermes
ALKS
$4.77B
| – | – |
-7,852
| Closed | -$339K |
|
240
Check Point Software Technologies
CHKP
$20.5B
| – | – |
-38,000
| Closed | -$3.03M |
|
241
Dynavax Technologies
DVAX
$1.17B
| – | – |
-379,932
| Closed | -$5.54M |
|
242
DexCom
DXCM
$31.7B
| – | – |
-60,652
| Closed | -$1.2M |
|
243
Hecla Mining
HL
$5.93B
| – | – |
-770,000
| Closed | -$3.8M |
|
244
Inogen
INGN
$220M
| – | – |
-193,524
| Closed | -$9.7M |
|
245
Standard BioTools
LAB
$493M
| – | – |
-54,132
| Closed | -$489K |
|
246
Altria Group
MO
$112B
| – | – |
-15,500
| Closed | -$1.07M |
|
247
NXP Semiconductors
NXPI
$56.8B
| – | – |
-19,780
| Closed | -$1.55M |
|
248
Oracle
ORCL
$626B
| – | – |
-709,912
| Closed | -$29.1M |
|
249
Comscore
SCOR
$32.8M
| – | – |
-2,169
| Closed | -$1.04M |
|
250
SPS Commerce
SPSC
$4.15B
| – | – |
-108,664
| Closed | -$3.3M |
|